NCT06843447
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06843447
Title A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)
Acronym MK-5909-003
Recruitment Recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Merck Sharp & Dohme LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ISR


No variant requirements are available.